Stay updated on Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Footer metadata updated to Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T09:42:59.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.2.0 to v3.3.2. The update appears limited to site version display and does not affect study data or functionality.
    Difference
    0.0%
    Check dated 2025-11-24T17:52:18.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Removed the government funding/status notice banner from the page, a non-core site-wide element that does not alter the study record, data, or user navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:29:12.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Record History now displays additional version entries with updated timestamps, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T09:57:14.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding lapse notice and confirms the NIH Clinical Center is open, with status sources listed, and a version upgrade to v3.2.0.
    Difference
    8%
    Check dated 2025-10-05T14:26:04.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T09:46:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.